Beyond the question of whether or not the association between prolonged exposure to prolactin-increasing antipsychotics in women with schizophrenia and other nonaffective psychotic disorders is causal, women receiving prolactin-increasing antipsychotics appear to have significantly increased odds of breast cancer. Here, PRL is linked to breast cancer.